Abstract
An 85-year-old male presented with a case of erythroderma secondary to lisinopril ingestion without a previous history of skin disease. While ACE inhibitors have been shown to elicit psoriatic erythroderma in previous cases, to our knowledge this is the first case report of iatrogenic …
Business Editors/Health & Medical Writers
NEWTOWN, Pa.–(BUSINESS WIRE)–Jan. 23, 2003
After only 7 months of availability, lisinopril, a generic version of the popular ACE inhibitors Prinivil and Zestril, has already significantly affected the cardiovascular market.
Since its launch in June 2002, lisinopril has gained acceptance on 97% of managed care formularies, according to Verispan’s Fall 2002 Managed Care Formulary Drug Audit. Lisinopril is largely replacing Prinivil a…
ABSTRACT: The clinical symptoms of drug-induced lupus (DIL) are similar to those of idiopathic systemic lupus erythematosus. The literature indicates that in patients with DIL, sera generally contain antinuclear antibodi…
Medicure Inc. (TSX: MPH)(AMEX: MCU), a cardiovascular-focused biopharmaceutical company, today announced that the positive results from the Phase II MATCHED study, which evaluated the combination of MC-1 and lisinopril in pa…
WASHINGTON–Several generic drug manufacturers have received Food and Drug Administration approval for their versions of Prinzide and Zestril, brand name hypertension drugs manufactured by AstraZeneca and Merck & Co., respectively. Each uses the same active ingredient–lisinopril.
Unlike the case involving many high-profile brands losing patent protection, neither AstraZeneca nor Merck contested the patent expirations for the pro…
Business Editors/Medical Writers
Mylan Laboratories Inc. (NYSE: MYL) announced today that the U.S. Food and Drug Administration (FDA) has approved its Abbreviated New Drug Applications (ANDAs) for Lisinopril Tablets in 2.5 mg, 5 mg, 10 mg, 20 mg, 30 mg, and 40 mg strengths and Lisinopril and Hydrochlorothiazide Tablets in 10 mg/12.5 mg, 20 mg/12.5 mg, and 20 mg/25 mg strengths.
Most Popular
Job Interviewing: How To Sell Yourself Like A Product…
